ATE345121T1 - Verwendung von konjugierter linolsäure zur behandlung der erkältung - Google Patents

Verwendung von konjugierter linolsäure zur behandlung der erkältung

Info

Publication number
ATE345121T1
ATE345121T1 AT04252434T AT04252434T ATE345121T1 AT E345121 T1 ATE345121 T1 AT E345121T1 AT 04252434 T AT04252434 T AT 04252434T AT 04252434 T AT04252434 T AT 04252434T AT E345121 T1 ATE345121 T1 AT E345121T1
Authority
AT
Austria
Prior art keywords
common cold
treat
linolic acid
conjugated linolic
mammal
Prior art date
Application number
AT04252434T
Other languages
English (en)
Inventor
Marianne O'shea
Ulrike Schmid
Ingrid Celestina Maria Mohede
Frederick William Cain
Original Assignee
Loders Croklaan Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Loders Croklaan Bv filed Critical Loders Croklaan Bv
Application granted granted Critical
Publication of ATE345121T1 publication Critical patent/ATE345121T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT04252434T 2003-07-16 2004-04-27 Verwendung von konjugierter linolsäure zur behandlung der erkältung ATE345121T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/619,549 US20050014832A1 (en) 2003-07-16 2003-07-16 Treatment

Publications (1)

Publication Number Publication Date
ATE345121T1 true ATE345121T1 (de) 2006-12-15

Family

ID=33477076

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04252434T ATE345121T1 (de) 2003-07-16 2004-04-27 Verwendung von konjugierter linolsäure zur behandlung der erkältung

Country Status (11)

Country Link
US (2) US20050014832A1 (de)
EP (1) EP1498119B1 (de)
JP (1) JP2005035975A (de)
KR (2) KR20050010464A (de)
AT (1) ATE345121T1 (de)
AU (1) AU2003257514B2 (de)
CA (1) CA2465681A1 (de)
DE (1) DE602004003173T2 (de)
ES (1) ES2280907T3 (de)
PL (1) PL1498119T3 (de)
PT (1) PT1498119E (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080193550A1 (en) * 2004-05-11 2008-08-14 Fonterra Corporate Research And Development Limited Cla-Enriched Milkfat and Uses Thereof
NZ543486A (en) * 2005-11-10 2009-03-31 Fonterra Corporate Res And Dev Compositions of CIS-9, trans-11 conjugated linoleic acid and vaccenic acid and uses thereof
JP2008115168A (ja) * 2006-10-12 2008-05-22 Daiichi Sankyo Healthcare Co Ltd 抗アデノウイルス剤
CN103781158A (zh) * 2013-11-30 2014-05-07 北京智谷睿拓技术服务有限公司 无线网络接入方法及接入装置
US11197824B2 (en) * 2020-01-16 2021-12-14 David Changaris Solution and method for reducing the virulence of viruses, bacteria,yeasts, or fungus
CN111743888B (zh) * 2020-06-16 2021-10-22 广州医科大学附属第一医院 (2z,4e)-2,4-癸二烯酸在制备用于治疗流感病毒引起的炎症的药物方面的应用
EP4243805A1 (de) * 2020-08-07 2023-09-20 Gbiotech S.À.R.L. Kombinationstherapien zur behandlung von coronavirusinfektion

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293358A (en) * 1980-05-07 1981-10-06 The Firestone Tire & Rubber Company Method and apparatus for accurately positioning a bead bundle
US4851437A (en) * 1986-08-12 1989-07-25 Elena Avram Tung oil compositions and use for treatment of body deficiencies
EP0396251A3 (de) * 1989-03-31 1992-07-08 National University Of Singapore Verwendung von Fettsäuren zur Behandlung von mit Cytokinen assoziierten Krankheiten
US5674901A (en) * 1995-06-01 1997-10-07 Wisconsin Alumni Research Foundation Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations
US5585400A (en) * 1996-02-27 1996-12-17 Wisconsin Alumni Research Foundation Methods of attenuating the allergic response in animals
US6674901B1 (en) * 1999-04-21 2004-01-06 Hewlett-Packard Development Company, L.P. Document analysis system and method
US6077868A (en) * 1999-07-20 2000-06-20 Wisconsin Alumni Research Foundation Selective inhibition of cyclooxygenase-2
EP1097708B1 (de) * 1999-11-02 2003-09-17 Loders Croklaan B.V. Verwendung von trans-trans-Isomeren von konjugierter Linolsäure
US20030215465A1 (en) * 2002-04-25 2003-11-20 Lc Usa Llc Use of conjugated acid derivatives
JP2004010551A (ja) * 2002-06-07 2004-01-15 Nippon Shokubai Co Ltd ビニルエーテル基含有（メタ）アクリル酸エステル類の製造方法
US6897327B2 (en) * 2003-05-08 2005-05-24 Stepan Company Manufacture of conjugated linoleic salts and acids

Also Published As

Publication number Publication date
AU2003257514B2 (en) 2006-10-19
PL1498119T3 (pl) 2007-01-31
KR20080005335A (ko) 2008-01-11
CA2465681A1 (en) 2005-01-16
DE602004003173T2 (de) 2007-09-27
EP1498119B1 (de) 2006-11-15
US20050038118A1 (en) 2005-02-17
KR100858988B1 (ko) 2008-09-17
JP2005035975A (ja) 2005-02-10
AU2003257514A1 (en) 2005-02-03
US20050014832A1 (en) 2005-01-20
KR20050010464A (ko) 2005-01-27
EP1498119A1 (de) 2005-01-19
ES2280907T3 (es) 2007-09-16
DE602004003173D1 (de) 2006-12-28
PT1498119E (pt) 2007-01-31

Similar Documents

Publication Publication Date Title
CY1123084T1 (el) Θεραπεια των ασθενειων αποθηκευσης γλυκογονου τυπου ιι
NO20070561L (no) Sammensetninger og fremgangsmater for a behandle oyesykdommer og tilstander.
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
BR0114054A (pt) Método para tratar alergias usando pirazóis substituìdos
EA200802054A1 (ru) Ингибиторы фермента
EP1809280A4 (de) Mitotische kinesinhemmer und verfahren zu ihrer verwendung
SE0301882D0 (sv) New use I
DE60312309D1 (de) Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten
SE0301886D0 (sv) New use V
BR9809115A (pt) Métodos para tratar inflamação e doenças inflamatórias usando inibidores de padprt
ATE362363T1 (de) Verwendung von tnf-alpha inhibitoren zur behandlung von nervenwurzelschäden
ATE241358T1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
BR0312232A (pt) Inibidores de caspases e seus usos
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
BR0208052A (pt) Composição que inibe matriz metaloproteinases para o tratamento de doenças neoplásicas
BRPI0417674A (pt) método para tratar a inflamação aguda em animais, com inibidores de quinase map p38
DE602004023762D1 (de) Für die behandlung von alzheimer-krankheit und ähnlichen leiden geeignete 1-alkyl-3-thiosubstituierte indol-2-alkinsäuren
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
ATE345121T1 (de) Verwendung von konjugierter linolsäure zur behandlung der erkältung
BR0306855A (pt) Método para o tratamento de distúrbios cognitivos
ATE415965T1 (de) Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung
DE60015791D1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
DE69932922D1 (de) Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
CY1106155T1 (el) Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties